# OnCo record hypopharyngeal-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/hypopharyngeal-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "hypopharyngeal-cancer" ;
  schema:name "Hypopharyngeal cancer"@en ;
  schema:alternateName "Hypopharynx cancer"@en, "Pyriform sinus cancer"@en, "Piriform fossa cancer"@en, "Postcricoid cancer"@en ;
  schema:description "Cancer of the hypopharynx, the funnel behind the voice box, is the head and neck cancer with the worst outlook because it grows silently and spreads to the neck early. Treatment is chemoradiation to keep the larynx where possible, or removal of the larynx and pharynx with reconstruction for the most extensive tumours."@en ;
  schema:url <https://onco.cc/cancers/hypopharyngeal-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hypopharyngeal_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Hypopharyngeal_cancer> ;
  onco:tag "subtype-page", "head-and-neck" ;
  onco:keyPapers <https://onco.cc/key-papers/paper-bonner-cetuximab-radiotherapy-nejm-2006/>, <https://onco.cc/key-papers/paper-eortc-24891-larynx-preservation-lefebvre-jnci-1996/> ;
  onco:pipeline <https://onco.cc/trials/nivopostop/>, <https://onco.cc/trials/keynote-689/>, <https://onco.cc/technologies/adaptive-radiotherapy/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:standardOfCare <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/tors/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/trials/rtog-91-11/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/trials/bonner-cetuximab-rt/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/trials/keynote-048/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/>, <https://onco.cc/technologies/smoking-cessation-after-diagnosis/>, <https://onco.cc/technologies/alcohol-reduction-labelling/> .